Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

220 results

Filters applied: . Clear all
Page 1
Physical Activity and Obesity Risk in Adults in Colombia: The Prospective Urban Rural Epidemiology (PURE) Study.
O'Donovan G, Martínez D, López-López JP, Otero J, Urina M, Vasquez T, Niño M, Narvaez C, Campo MC, Perez-Mayorga M, Rodríguez S, Arcos E, Sanchez G, García H, Rangarajan S, Yusuf S, López-Jaramillo P. O'Donovan G, et al. Among authors: yusuf s. Med Sci Sports Exerc. 2024 Feb 24. doi: 10.1249/MSS.0000000000003413. Online ahead of print. Med Sci Sports Exerc. 2024. PMID: 38648672
Effects of statin therapy on diagnoses of new-onset diabetes and worsening glycaemia in large-scale randomised blinded statin trials: an individual participant data meta-analysis.
Cholesterol Treatment Trialists’ (CTT) Collaboration. Electronic address: ctt@ndph.ox.ac.uk; Cholesterol Treatment Trialists’ (CTT) Collaboration. Cholesterol Treatment Trialists’ (CTT) Collaboration. Electronic address: ctt@ndph.ox.ac.uk, et al. Lancet Diabetes Endocrinol. 2024 May;12(5):306-319. doi: 10.1016/S2213-8587(24)00040-8. Epub 2024 Mar 27. Lancet Diabetes Endocrinol. 2024. PMID: 38554713
We aimed to address these gaps in knowledge through analysis of individual participant data from large, long-term, randomised, double-blind trials of statin therapy. METHODS: We conducted a meta-analysis of individual participant data from randomised controlled trials of s …
We aimed to address these gaps in knowledge through analysis of individual participant data from large, long-term, randomised, double …
Relationship Between Social Support and Clinical Outcomes: An Evaluation of Participant-Nominated Treatment Supporters in the HOPE 4 Intervention.
Drakos A, McCready T, Lopez-Jaramillo P, Islam S, McKee M, Yusuf S, Schwalm JD. Drakos A, et al. Among authors: yusuf s. Circ Cardiovasc Qual Outcomes. 2024 Apr;17(4):e009342. doi: 10.1161/CIRCOUTCOMES.122.009342. Epub 2024 Mar 5. Circ Cardiovasc Qual Outcomes. 2024. PMID: 38440889
The majority of survey respondents from either study group strongly agreed that having a treatment supporter positively influenced their health. CONCLUSIONS: Long-term support from a nominated treatment supporter was associated with improved adherence, risk factor manageme …
The majority of survey respondents from either study group strongly agreed that having a treatment supporter positively influenced their hea …
Long-term cardiovascular risks and the impact of statin treatment on socioeconomic inequalities: a microsimulation model.
Wu R, Williams C, Zhou J, Schlackow I, Emberson J, Reith C, Keech A, Robson J, Armitage J, Gray A, Simes J, Baigent C, Mihaylova B; CTT Collaboration secretariat; Armitage J, Baigent C, Barnes E, Blackwell L, Collins R, Davies K, Emberson J, Fulcher J, Halls H, Herrington WG, Holland L, Keech A, Kirby A, Mihaylova B, O'Connell R, Preiss D, Reith C, Simes J, Wilson K; CTT Collaboration trialists: A to Z trial (phase Z); Blazing M, Braunwald E, Lemos J, Murphy S, Pedersen TR, Pfeffer M, White H, Wiviott S; AFCAPS/TEXCAPS (AirForce/Texas Coronary Atherosclerosis Prevention Study); Clearfield M, Downs JR, Gotto A Jr, Weis S; ALERT (Assessment of Lescol in Renal Transplantation); Fellström B, Holdaas H, Jardine A, Pedersen TR; ALLHAT (Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial); Gordon D, Davis B, Furberg C, Grimm R, Pressel S, Probstfield JL, Rahman M, Simpson L; ALLIANCE (Aggressive Lipid-Lowering Initiation Abates New Cardiac Events); Koren M; ASCOT (Anglo-Scandinavian Cardiac Outcomes Trial); Dahlöf B, Gupta A, Poulter N, Sever P, Wedel H; ASPEN (Atorvastatin Study for the Prevention of Coronary Heart Disease Endpoints in Non-Insulin Dependent Diabe… See abstract for full author list ➔ Wu R, et al. Among authors: yusuf s. Br J Gen Pract. 2024 Feb 19;74(740):e189-98. doi: 10.3399/BJGP.2023.0198. Online ahead of print. Br J Gen Pract. 2024. PMID: 38373851 Free PMC article.
CONCLUSION: The study demonstrated the potential of guideline-recommended statin treatment to reduce socioeconomic inequalities. This CVD model is a novel resource for individualised long-term projections of health outcomes of CVD treatments....
CONCLUSION: The study demonstrated the potential of guideline-recommended statin treatment to reduce socioeconomic inequalities. This CVD mo …
Premature senescence and cardiovascular disease following cancer treatments: mechanistic insights.
Jain A, Casanova D, Padilla AV, Paniagua Bojorges A, Kotla S, Ko KA, Samanthapudi VSK, Chau K, Nguyen MTH, Wen J, Hernandez Gonzalez SL, Rodgers SP, Olmsted-Davis EA, Hamilton DJ, Reyes-Gibby C, Yeung SJ, Cooke JP, Herrmann J, Chini EN, Xu X, Yusuf SW, Yoshimoto M, Lorenzi PL, Hobbs B, Krishnan S, Koutroumpakis E, Palaskas NL, Wang G, Deswal A, Lin SH, Abe JI, Le NT. Jain A, et al. Among authors: yusuf sw. Front Cardiovasc Med. 2023 Sep 14;10:1212174. doi: 10.3389/fcvm.2023.1212174. eCollection 2023. Front Cardiovasc Med. 2023. PMID: 37781317 Free PMC article. Review.
Recent evidence indicates that cancer and its treatments can lead to long-term complications, including CVD. Cellular senescence, a hallmark of aging, is implicated in CVD pathogenesis, particularly in cancer survivors. ...
Recent evidence indicates that cancer and its treatments can lead to long-term complications, including CVD. Cellular senescence, a h …
Outcomes of Patients Treated With RCHOP With a PET-Adapted Approach for Consolidative Radiotherapy: A Retrospective Single-Center Study at the Royal Marsden Hospital.
Li S, Sharma B, Yusuf S, Michalarea V, Gleeson M, Hickmott L, Wotherspoon A, Attygalle AD, Vroobel K, O'Connor S, Du Y, Kuhnl A, Iyengar S, El-Sharkawi D, Chau I, Cunningham D. Li S, et al. Among authors: yusuf s. Clin Lymphoma Myeloma Leuk. 2024 Jan;24(1):48-54. doi: 10.1016/j.clml.2023.08.021. Epub 2023 Aug 29. Clin Lymphoma Myeloma Leuk. 2024. PMID: 37734988
Overtreatment with CRT for patients who may have already been cured by primary immunochemotherapy in the rituximab era is a significant concern due to the long-term toxicity associated with radiotherapy. Positron emission tomography (PET) may help to identify patients who …
Overtreatment with CRT for patients who may have already been cured by primary immunochemotherapy in the rituximab era is a significant conc …
Systematic review of the results of fenestrated endovascular aortic repair in octogenarians.
Elahwal M, Richards T, Imsirovic A, Bagga R, Almond G, Yusuf SW. Elahwal M, et al. Among authors: yusuf sw. Ann R Coll Surg Engl. 2024 Feb;106(2):106-117. doi: 10.1308/rcsann.2023.0032. Epub 2023 Aug 29. Ann R Coll Surg Engl. 2024. PMID: 37642117 Free PMC article.
No statistically significant differences were found between octogenarians and non-octogenarians. Long-term survival was significantly lower for octogenarians in two studies. ...
No statistically significant differences were found between octogenarians and non-octogenarians. Long-term survival was significantly …
Delineating COVID-19 subgroups using routine clinical data identifies distinct in-hospital outcomes.
Rangelov B, Young A, Lilaonitkul W, Aslani S, Taylor P, Guðmundsson E, Yang Q, Hu Y, Hurst JR, Hawkes DJ, Jacob J; Тhe NCCID Collaborative. Rangelov B, et al. Sci Rep. 2023 Jun 20;13(1):9986. doi: 10.1038/s41598-023-32469-9. Sci Rep. 2023. PMID: 37339958 Free PMC article.
We adapted an unsupervised data-driven model-SuStaIn, to be utilised for short-term infectious disease like COVID-19, based on 11 commonly recorded clinical measures. ...
We adapted an unsupervised data-driven model-SuStaIn, to be utilised for short-term infectious disease like COVID-19, based on 11 com …
ACT trials: long-term outcomes.
Eikelboom JW, Belley-Cote E, Whitlock RP, Jolly SS, Wasserman S, Yusuf S; ACT Trials Steering Committee. Eikelboom JW, et al. Among authors: yusuf s. Lancet Respir Med. 2023 Jun;11(6):e50. doi: 10.1016/S2213-2600(23)00148-0. Lancet Respir Med. 2023. PMID: 37263712 Free PMC article. No abstract available.
Global Variations in Heart Failure Etiology, Management, and Outcomes.
G-CHF Investigators; Joseph P, Roy A, Lonn E, Störk S, Floras J, Mielniczuk L, Rouleau JL, Zhu J, Dzudie A, Balasubramanian K, Karaye K, AlHabib KF, Gómez-Mesa JE, Branch KR, Makubi A, Budaj A, Avezum A, Wittlinger T, Ertl G, Mondo C, Pogosova N, Maggioni AP, Orlandini A, Parkhomenko A, ElSayed A, López-Jaramillo P, Grinvalds A, Temizhan A, Hage C, Lund LH, Kazmi K, Lanas F, Sharma SK, Fox K, McMurray JJV, Leong D, Dokainish H, Khetan A, Yonga G, Kragholm K, Wagdy Shaker K, Mwita JC, Al-Mulla AA, Alla F, Damasceno A, Silva-Cardoso J, Dans AL, Sliwa K, O'Donnell M, Bazargani N, Bayés-Genís A, McCready T, Probstfield J, Yusuf S. G-CHF Investigators, et al. Among authors: yusuf s. JAMA. 2023 May 16;329(19):1650-1661. doi: 10.1001/jama.2023.5942. JAMA. 2023. PMID: 37191704 Free PMC article.
The proportional risk of death within 30 days of a first hospital admission was 3- to 5-fold higher in lower-middle-income countries and low-income countries compared with high-income countries after adjusting for patient characteristics and use of long-term HF therapies. …
The proportional risk of death within 30 days of a first hospital admission was 3- to 5-fold higher in lower-middle-income countries and low …
220 results